top of page
Browse by category
Search


OIKOS launches cultured dairy drink to help build and retain muscle mass during weight loss
OIKOS has introduced OIKOS FUSION, which according to the company is the first of its kind, nutrient-dense cultured dairy drink developed...


Allurion to increase focus on low-dose GLP-1 combination therapy and muscle mass maintenance
Allurion Technologies has revealed a strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass...


Allurion submits final PMA module for Allurion Balloon to the FDA
Allurion Technologies has submitted the fourth and final module of the Pre-Market Approval (PMA) application to the FDA and additional,...


Morphic Medical gains CE Mark for RESET endoscopic device
Morphic Medical has received CE (Conformité Européenne) Mark approval for the RESET System, which according to the company is designed to...


First dual GCG/GLP-1ra gains approval from China’s NMPA for chronic weight management
China's National Medical Products Administration (NMPA) has approved Innovent Biologics’ mazdutide, a first-in-class dual glucagon...


Levita Magnetics' Magnetic Surgical System gains indication for bariatric and hiatal hernia repair procedures
Levita Magnetics has gained FDA clearance for the use of its Magnetic Surgical System (MSS), combined with the MARS system, in bariatric...


Johnson & Johnson MedTech launches the ETHICON 4000 Stapler
Johnson & Johnson MedTech has launched the ETHICON 4000 Stapler, an advanced surgical stapler designed to manage tissue complexities and...


Johnson & Johnson MedTech launches the DUALTO Energy System combining multiple energy modalities into an integrated platform for use across open and minimally invasive surgery
Johnson & Johnson MedTech has launched the DUALTO Energy System, a surgical solution that combines multiple energy modalities into an...


Novo Nordisk and Septerna to develop oral small molecule medicines for obesity
Novo Nordisk and Septerna have announced an exclusive global collaboration and license agreement to discover, develop and commercialise...


Fractyl Health submits of CTA module in Europe for RJVA-001
Fractyl Health has submitted the first module of its Clinical Trial Application (CTA) in Europe for the company’s gene therapy candidate...
Browse by tag






bottom of page

